If You're Considering Ultherapy in Gangnam
If you've started to feel that your skin isn't as firm as it once was, you've probably come across the name "Ultherapy" at least once. It's often mentioned as a lifting option that doesn't require surgery, but it's surprisingly hard to find information that calmly lays out "exactly how it works and how long the results last" and "where and how you should get a consultation in Gangnam."
In this article, we've organized how Dr. Kim Gun-woo, Medical Director of Cellinique on Dosan-daero in Gangnam, consults on Ultherapy, the order in which the procedure is carried out, and how he explains its effects and safety. If you're curious about comparisons with other lifting procedures, take a look at our lifting procedure comparison guide or the Ultherapy treatment information page as well.
3-Line Summary
1. Ultherapy is a non-invasive lifting procedure that delivers microfocused ultrasound with visualization (MFU-V) into the deeper layers of the skin (1.5, 3.0, and 4.5mm) to stimulate your own collagen production without any incision.
2. The device received the FDA De Novo classification decision DEN080006/K072505 in 2009, followed by separate later 510(k) clearances, and indications for the neck, under-chin, and décolletage were added later. (Keep the 2009 De Novo record distinct from the later 510(k) submissions.)
3. Results appear not immediately after the procedure but gradually over a span of weeks to months, and both how long they last and how noticeable they are vary significantly from person to person. The specific plan is decided during your pre-procedure consultation at Cellinique on Dosan-daero in Gangnam.
1. What Is Ultherapy? The Principle of Microfocused Ultrasound (MFU-V)
Ultherapy is a non-invasive lifting procedure that uses microfocused ultrasound (MFU-V). Unlike lasers, which use light energy, Ultherapy delivers ultrasound energy concentrated at a set depth without touching the surface of the skin. That's why it's often introduced as "lifting without a scalpel."
Here's how it works. When ultrasound energy is concentrated at a set depth within the skin (typically 1.5mm, 3.0mm, and 4.5mm), small thermal coagulation points form at those spots. The 4.5mm depth in particular corresponds to the superficial musculoaponeurotic system (SMAS) layer — the very layer that is lifted and tightened in a facelift. These tiny thermal stimuli denature collagen and, over time, are reported to prompt fibroblasts to produce new collagen and elastin fibers. So Ultherapy is less of a procedure that "pulls things tight right away" and more of one that helps the skin rebuild its own elastic structure.
Histological studies report that MFU-V creates thermal coagulation points at depths of 1.5mm (superficial dermis), 3.0mm (deep dermis), and 4.5mm (SMAS/platysma), denaturing collagen and prompting HSP47-positive fibroblasts to generate new collagen and elastin fibers. The response progresses through transient inflammation → proliferation → remodeling without damage to the epidermis, and changes appear gradually with degree and longevity varying from person to person. (Sources: PMC11743342 Marquardt et al., J Cosmet Dermatol 2024 · PMC12374570 literature review, J Cosmet Dermatol 2025)
That said, because collagen production proceeds slowly over time, this is not a procedure that is "completed on the day of treatment." It's more realistic to separate your expectations into the changes seen right after the procedure and those that unfold over the following weeks to months.
In One Line
It's a non-invasive lifting procedure that uses ultrasound thermal stimulation to help the deeper layers of the skin rebuild collagen. How it's carried out, whether it suits you, and how long it lasts differ from person to person and are decided during your pre-procedure consultation at Cellinique on Dosan-daero in Gangnam.
2. Ultherapy at a Glance
| Item | Details |
|---|---|
| Method | Non-invasive lifting based on microfocused ultrasound (MFU-V) (no incision) |
| Working depths | Typically 1.5mm, 3.0mm, and 4.5mm (4.5mm is the SMAS layer) |
| Primary action | Stimulating self-generated collagen and elastin fibers via thermal coagulation points |
| Overseas regulatory documents | U.S. FDA De Novo classification decision (DEN080006/K072505, 2009) and later separate 510(k) submissions for their stated devices and indications; each document must be read within its own scope |
| Anesthesia | Topical numbing cream, etc. (depending on the treatment area and extent) |
| Downtime | Generally on the shorter side, but temporary redness, swelling, and tenderness vary greatly between individuals |
| Pattern of perceived results | Gradual changes over weeks to months rather than right after the procedure; varies greatly between individuals |
| Longevity | Varies greatly between individuals and is not guaranteed (realistically explained during the pre-procedure consultation) |
| Consultation & procedure by | Dr. Kim Gun-woo, Medical Director, performs consultations and procedures directly |
| Location | Cellinique on Dosan-daero in Gangnam |
| Examples requiring careful review | Pregnancy or breastfeeding, active infection or wounds in the treatment area, a tendency toward keloids, metal implants or prostheses in the treatment area, etc. — assessed during the pre-procedure consultation |
※ The above is general guidance, and whether Ultherapy is right for you and exactly how it would proceed can only be decided through a pre-procedure consultation. How you perceive the results and how suitable it is differ depending on your individual skin and health condition.
3. For Which Concerns Do We Consider Ultherapy Together?
Ultherapy isn't a procedure we recommend to everyone. In our consultations, we typically consider whether it might be an option for those who describe concerns like the following.
If You Have Concerns Like These
- Those bothered by sagging and reduced firmness along the cheeks and jawline
- Those concerned about laxity under the chin and around the neck
- Those who find surgery daunting but want to consider non-invasive firmness care
- Those thinking about the procedure within the framework of long-term skin care rather than a single result
Of course, having these concerns doesn't mean Ultherapy is always the answer. It simply means it's one of the options to review during a consultation. When sagging is significant or there's a lot of skin laxity, another approach may be more suitable, so whether it actually fits you is decided during the pre-procedure consultation based on your individual condition.
Conversely, We're Cautious in These Cases
- If you are pregnant, breastfeeding, or planning to be
- If there is an active infection, wound, or inflammation in the treatment area
- If you have a tendency toward keloids or hypertrophic scarring
- If there are metal implants or prostheses in the treatment area
- If severe or cystic acne is present in the treatment area
If even one of the above applies to you, please be sure to let us know in advance during the pre-procedure consultation. We'll confirm whether the procedure is possible and, if needed, help you consider other care options as well.
4. What Does the Process Look Like?
At Cellinique, we carry out Ultherapy in the following order. Because this is a procedure where the design of the energy delivery depth and area, along with recovery management, affects the outcome, we try to keep the process simple and stable.
- Pre-procedure consultation + skin assessment — Dr. Kim Gun-woo personally reviews the degree of skin sagging, firmness, history of past procedures, and lifestyle habits. Whether Ultherapy is suitable is usually decided at this stage.
- Area and depth design — We review which areas will receive energy at which depths (1.5, 3.0, 4.5mm), as well as combinations and sequencing with other procedures.
- Anesthesia and preparation — Depending on the area and extent, we explain ways to reduce discomfort, such as topical numbing cream.
- Procedure application — We deliver energy to the set depths while confirming the layers with ultrasound imaging. (The amount of energy, depth, and number of lines are designed individually to match the area and condition.)
- Aftercare + next follow-up guidance — We separately provide post-procedure precautions, recovery checkpoints, and, if needed, the timing of your next follow-up.
What to confirm in consultation
The appropriate procedure or care plan can vary with current condition and goals. Review individual suitability, realistic expectations, and the recovery process during consultation.
5. How Do We Explain Results and Longevity?
The changes from Ultherapy aren't completed on the day of the procedure. Because it takes time for new collagen and elastin fibers to form, you'll usually observe changes gradually over a span of weeks to months.
Clinical research confirms that MFU-V's effects are delayed, with studies primarily evaluating outcomes at 90 and 180 days; some reported sustained improvement out to 12 months or more. Elasticity indices have been reported to increase significantly at 12 and 24 weeks post-procedure, but the degree of improvement varies widely between individuals — a mix of mild to significant improvement. As a result, a uniform guarantee like "lasts several years" is not possible, and longevity and how noticeable results are vary from person to person. (Sources: PMC12374570 literature review, J Cosmet Dermatol 2025 · PMC6336023 Kerscher et al., Clin Cosmet Investig Dermatol 2019)
That's why, at Cellinique, instead of definitive claims like "you'll look X years younger" or "it lasts X years," we work with you during the consultation to outline a realistic range of change you can expect for your own skin. Whether it's a one-time procedure or something to repeat over time within a care plan also differs depending on your individual condition.
6. How Do We Manage Downtime and Recovery?
Because Ultherapy involves no incision, downtime tends to be short, but given the nature of ultrasound thermal stimulation, temporary reactions can occur, and there are differences depending on your recovery capacity and lifestyle habits.
Reactions We Commonly Mention Right After the Procedure
- Temporary redness and a warm sensation in the treatment area
- Mild swelling and tenderness (often subsiding within a few days)
- Temporary tingling or a feeling of tightness, depending on the area
- Rarely, temporary bruising (which often resolves over time)
For a Few Days After the Procedure
- Please briefly avoid irritating cosmetics, intense heat (saunas, hot rooms), and strong massage
- Please apply thorough sun protection
- If you notice any change in your condition or skin, please feel free to contact Cellinique
The key point is that, since recovery patterns differ from person to person, it's important to go over the recovery process and follow-up schedule together in advance.
7. Safety Standards and Precautions
Ultherapy is, after all, a genuine medical procedure, so it's difficult to say there's no risk at all. Because the design of the energy delivery depth and area in particular affects both outcome and safety, Cellinique allows ample time for consultation, area design, and post-procedure follow-up.
Ultherapy (the Ulthera System) is a microfocused ultrasound device represented in an FDA De Novo classification decision from 2009 and separate later 510(k) submissions — for example K121700 for neck and under-chin and K134032 for décolletage (Ulthera, Inc.). This is 510(k) clearance, not PMA "approval." Clinical reports indicate it did not significantly impair the skin barrier or physiological indices, although temporary swelling and redness may be observed; in some reports, pain, nerve stimulation, or temporary sensory changes may be reported, with occurrence and degree varying from person to person. (Sources: U.S. FDA 510(k) medical device clearance information, accessdata.fda.gov, Ulthera, Inc. · PMC6336023, Clin Cosmet Investig Dermatol 2019)
Commonly Reported Reactions
- Temporary redness, swelling, and tenderness in the treatment area (with duration varying between individuals)
- Rarely, bruising or temporary sensory changes (numbness, dulled sensation)
- Very in some reports, temporary muscle weakness or nerve stimulation (usually recovering over time)
When You Should Contact Cellinique Immediately
- When severe swelling, heat, or redness in the treatment area persists
- Facial asymmetry or persistent sensory abnormalities
- Pain that progressively worsens
- Suspected allergic or abnormal skin reactions
What You Must Tell Us Before the Procedure
- Whether you are pregnant or breastfeeding (including if you are planning to be)
- A history of keloids or hypertrophic scarring
- A history of metal implants, prostheses, or filler treatments in the treatment area
- Whether there is active infection, wounds, or severe acne
- Other procedures you've had recently (the interval and sequencing may need adjusting)
The criteria for side effects, emergency response, contraindications, and infection control that apply to all procedures can be reviewed in detail on the Cellinique treatment safety information page. If you're considering Ultherapy, we recommend taking a look through it before the procedure.
8. Getting an Ultherapy Consultation on Dosan-daero in Gangnam — Cellinique
Cellinique is an anti-aging clinic located on Dosan-daero in Gangnam. For a procedure like Ultherapy, where the design of the energy delivery depth and area determines the outcome, we believe a structure in which the medical team consistently manages everything from consultation to procedure and post-procedure follow-up helps with the stability of the results.
It's run as a structure where Dr. Kim Gun-woo personally handles everything from the pre-procedure consultation to area design, the procedure, and post-procedure follow-up. Thanks to its location on Dosan-daero in Gangnam, the fact that revisits and follow-ups are convenient is also an advantage for a procedure like Ultherapy, where you observe changes over time. That said, without assigning a clinic ranking, compare based on whether the doctor personally consults and performs the procedure and whether the area design and aftercare are consistent.
| Category | Details |
|---|---|
| Location | Dosan-daero, Gangnam-gu, Seoul (near Dosan Park) |
| Consultation & procedure | By Dr. Kim Gun-woo, Medical Director, personally |
| Phone | 02-6203-3434 |
| Booking | By phone or KakaoTalk consultation |
Read Each FDA Record by Its Actual Regulatory Path and Scope
Describing the US history as a “first 510(k) approval in 2009” combines different regulatory paths. The FDA database identifies the 2009 record as De Novo DEN080006, linked to K072505. K121700, K132028, and K134032 are later, separate 510(k) records. De Novo classification, 510(k) clearance, and PMA approval should not be collapsed into the words “approval” or “certification”; record the document type, device, indication, and decision separately.
| FDA or research record | What to verify | Interpretation limit |
|---|---|---|
| DEN080006 / K072505 | The 2009 De Novo classification decision, device, and indication represented in that record. | Do not relabel it as the first 510(k), a PMA approval, or a blanket endorsement of every later model and use. |
| K121700 | The Class II OHV classification, stated indications for use, and substantial-equivalence decision for that submission. | The FDA letter itself explains that a substantial-equivalence determination is not a determination of compliance with every other requirement and does not guarantee an individual result. |
| K132028 | The Ulthera System configuration, included imaging elements, indications, and predicate comparison represented in that submission. | Do not expand the record to unlisted areas, nominal depths, energy settings, treatment effects, or every device generation. |
| K134032 | The specific indications and substantial-equivalence comparison for that later submission. | A later clearance does not automatically change the scope of prior records or prove superiority over other devices. |
| Systematic review of microfocused ultrasound (PMID 36674277) | The populations, treatment settings, outcome instruments, follow-up periods, and limitations represented across MFU studies. | An individual's exact magnitude of change, duration, pain, recovery date, cartridge plan, or clinic-level safety performance. |
Consultation record to request: Write down the actual device and model, the method used to verify the device and consumables, the proposed treatment area, each cartridge's nominal focal depth, the intended tissue target after individual anatomical assessment, the imaging method, and the energy or line plan. Values such as 1.5, 3.0, and 4.5 mm are nominal cartridge depths; they do not mean that one number reaches the same named tissue layer in every person and area. Ask how sensitive structures and areas outside the applicable indication are identified and avoided.
Pain, tenderness, edema, erythema, sensory change, burns, or other reported reactions cannot be converted into a promise of “rare” complications or a fixed recovery day without an appropriate denominator and plan-specific evidence. Ask for expected reactions, the signs that should prompt assessment, a direct contact route, and follow-up timing in writing. Voluntary adverse-event databases such as MAUDE can identify signals and case details, but they do not provide the total number of procedures needed to calculate an individual incidence rate.
Continuity of the treating clinician, location, and access to follow-up can be practical consultation factors, but a clinic's operating model does not by itself prove comparative safety, effectiveness, or stability of results. Obtain the current non-covered price with the area, line or energy plan, anesthesia, consumables, and follow-up inclusions documented. The decision should connect the actual FDA record and published evidence to the actual device, area, anatomy, and treatment plan rather than relying on the brand name alone.
Document traceability: Do not copy only an FDA submission number. Record the decision date, device and model, product code, indications for use, predicates, and relevant later submissions. When the device generation, software, or transducer changes, recheck whether that record applies to the configuration that would actually be used.
Regulatory documents and safety checks
Regulatory document
FDA K132028 is a 2013 510(k) clearance document. A 510(k) clearance is a substantial-equivalence determination for U.S. marketing; it does not mean Korean authorization or PMA approval.
Pain
A systematic review describes procedure pain as moderate. Do not minimize pain as rare; discuss pain management during and after the procedure and contact criteria.
Reactions and follow-up
Do not state a frequency or recovery course for adverse effects without product-specific evidence. Seek assessment without delay for sensory changes, muscle weakness, or severe or worsening pain.
Medicines and scheduling
Share medicines and supplements, important dates, and previous procedure reactions. Do not stop or change prescribed drugs on your own.
Frequently asked questions
What is FDA 510(k) clearance?
It is a substantial-equivalence determination for U.S. marketing, not Korean authorization or PMA approval. It does not guarantee an aesthetic outcome.
How should pain be discussed?
A systematic review describes procedure pain as moderate. Confirm pain management during and after the procedure and follow-up criteria.
When should adverse effects be assessed?
Seek assessment without delay for sensory changes, muscle weakness, or severe or worsening pain.
What should be confirmed at consultation?
Confirm device and transducer, area and plan, contraindications, possible reactions, and the follow-up and reassessment route.
How can costs be checked?
Published non-covered items and prices can be checked; final cost is explained after clinical evaluation.
Closing
This article is general information, not an individual diagnosis or treatment instruction. Discuss suitability, risks, and follow-up with a clinician.
